Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

Thumbnail

Treating type 2 diabetes with ertugliflozin does not increase risk of major cardiovascular events

The VERTIS CV Study tracked the performance of ertugliflozin and a placebo in more than 8,000 adult T2D patients.

Thumbnail

Update: FDA names 5 companies recalling extended-release metformin

The FDA has provided new information about the metformin recall first announced in May. 

Thumbnail

AI algorithm predicts glucose levels one hour into the future

Bio Conscious has announced that its AI-powered Diabits app can predict blood glucose levels a full hour into the future—and it has the data to prove it.

Thumbnail

Machine learning predicts drug cardiotoxicity

Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.

Thumbnail

Indoor air filters associated with a significant decrease in systolic blood pressure

Ambient air pollution directly leads to poorer health outcomes, and even short-term exposure to fine particulate matter can increase a person’s risk of adverse cardiovascular events.

Welldoc receives additional FDA approval for digital diabetes solution

Welldoc, a Columbia, Maryland-based digital health company, has gained an additional FDA approval for its BlueStar diabetes management solution.

Thumbnail

Healthcare groups encourage black women to monitor, manage their blood pressure

Numerous healthcare organizations have joined forces to launch a new ad campaign focused on helping black women learn more about monitoring and managing their blood pressure.

Thumbnail

International Society of Hypertension updates global treatment guidelines

The guidelines were specifically designed so that they could apply to patients from any country or socioeconomic group.